Brazil and the USA: Economic Reciprocity Law, Intellectual Property, Cotton Crisis, and the Impact of the Tariff Hike
Since the inauguration of the current President of the United States of America, Donald Trump, it has been no surprise that one of the immediate measures adopted by his administration regarding several countries has been the imposition of tariffs on imported products, without prior attempts at negotiation. There is an ongoing debate about the legality […]
Acquired distinctiveness in Brazil
The Brazilian Patent and Trademark Office (BPTO) has made significant strides in recognizing acquired distinctiveness in trademark law by publishing in the Official Bulletin No. 2840 of June 10, 2025, Ordinance No. 15/2025, which allows the possibility of demonstrating acquired distinctiveness through use during trademark examination. These instances are as follows: Corrobation is required to demonstrate […]
TOOLS FOR HUMANITY CASE: BRAZILIAN DPA UPHOLDS SUSPENSION OF PAYMENTS FOR IRIS COLLECTION
The company Tools for Humanity, which manufactures an advanced camera called ORB, had been collecting iris, facial, and eye data from individuals in exchange for financial compensation via a crypto asset known as World Coin (WLD). The stated purpose of iris collection, according to the company, was the development of a “unique human verification system” […]
Ozempic: The Expiration of Patent Exclusivity
Ozempic is the trademark used to designate the medication that contains the active ingredient known as semaglutide, which is used to treat diabetes. It has gained significant popularity in the Brazilian market due to its side effect of weight loss in patients who use the well-known injectable “pen.” Currently, the company Novo Nordisk A/S holds […]
